PHARMOCANN GLOBAL (Israel) Top Management

PHARMOCANN GLOBAL employes about 15 people. The company is managed by 15 executives with total tenure of roughly 48 years, averaging almost 3.0 years of service per executive having 1.0 employees per reported executive. Analysis of PHARMOCANN GLOBAL management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with PHARMOCANN GLOBAL future performance.
Check out Your Equity Center.


  Gil Hovesh  CEO
Chief Executive Officer, Director

PHARMOCANN GLOBAL Management Team Effectiveness

PHARMOCANN GLOBAL has return on total asset (ROA) of (11.64) % which means that it has lost $11.64 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (18.92) %, meaning that it generated substantial loss on money invested by shareholders. PHARMOCANN GLOBAL management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

PHARMOCANN GLOBAL Workforce Comparison

PHARMOCANN GLOBAL is considered to be number one stock in number of employees category among related companies. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 30.0. PHARMOCANN GLOBAL totals roughly 15.0 in number of employees claiming about 50% of equities under Drug Manufacturers—Specialty & Generic industry.


The company has Profit Margin (PM) of (23.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (29.17) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.29.

PHARMOCANN GLOBAL Notable Stakeholders

A PHARMOCANN GLOBAL stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PHARMOCANN GLOBAL often face trade-offs trying to please all of them. PHARMOCANN GLOBAL's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PHARMOCANN GLOBAL's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gil Hovesh - Chief Executive Officer, DirectorProfile
Ori Mor - Chief Financial OfficerProfile
Eyal Sandach - Chief Operating Officer, General ManagerProfile
Yehuda Peretz - Head Security Officer at Pharmocann Ltd.Profile
Keren Tzlill - External DirectorProfile
Daniel Spira - Internal AuditorProfile
Dan Gillerman - Chairman of the BoardProfile
Liran Halfon - DirectorProfile
Yosef Alharal - External DirectorProfile
Benjamin Rosenstein - Head Formulator at Pharmocann Ltd.Profile
Nitzan Levy - Head of Training and Customer Services at Pharmocann Ltd.Profile
Avital Perelstein - Vice President - FinanceProfile
Dan Eidelman - Vice President-Strategy at Pharmocann Ltd.Profile
Roi Hovesh - Vice President-Operations at Pharmocann Ltd.Profile
Orly Guy - Independent DirectorProfile

PHARMOCANN GLOBAL Workforce Analysis

Traditionally, organizations such as PHARMOCANN GLOBAL use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PHARMOCANN GLOBAL within its industry.

PHARMOCANN GLOBAL Manpower Efficiency

Return on PHARMOCANN GLOBAL Manpower

Revenue Per Employee2.2 M
Revenue Per Executive2.2 M
Net Loss Per Employee495.3 K
Net Loss Per Executive495.3 K
Check out Your Equity Center. Note that the PHARMOCANN GLOBAL information on this page should be used as a complementary analysis to other PHARMOCANN GLOBAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Tools for PHARMOCANN Stock

When running PHARMOCANN GLOBAL price analysis, check to measure PHARMOCANN GLOBAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PHARMOCANN GLOBAL is operating at the current time. Most of PHARMOCANN GLOBAL's value examination focuses on studying past and present price action to predict the probability of PHARMOCANN GLOBAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PHARMOCANN GLOBAL's price. Additionally, you may evaluate how the addition of PHARMOCANN GLOBAL to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges